BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.16% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.71% |
| 4 | Healthcare | 5.18% |
| 5 | Communication Services | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
New Oriental
EDU
$8.36B
| $3.52M | ﹤0.01% |
306,191
-123,732
| -29% | -$1.8M |
|
1352
Insulet
PODD
$9.94B
| $3.5M | ﹤0.01% |
13,151
-4,333
| -25% | -$1.06M |
|
1353
Cenovus Energy
CVE
$57.2B
| $3.5M | ﹤0.01% |
+209,875
| New | +$3.18M |
|
1354
Asbury Automotive
ABG
$3.78B
| $3.49M | ﹤0.01% |
21,814
-10,705
| -33% | -$1.87M |
|
1355
Vanguard High Dividend Yield ETF
VYM
$84B
| $3.49M | ﹤0.01% |
+31,119
| New | +$3.47M |
|
1356
Silicon Laboratories
SLAB
$7.29B
| $3.48M | ﹤0.01% |
23,156
-2,535
| -10% | -$405K |
|
1357
PUT
Generac Holdings
GNRC
$12.9B
| $3.48M | ﹤0.01% |
+117
| New | +$35.1K |
|
1358
Brinker International
EAT
$10.2B
| $3.46M | ﹤0.01% |
90,783
+8,139
| +10% | +$304K |
|
|
VRNT
1359
DELISTED
Verint Systems
VRNT
| $3.46M | ﹤0.01% |
66,965
-124,798
| -65% | -$6.41M |
|
1360
Cullen/Frost Bankers
CFR
$10.6B
| $3.46M | ﹤0.01% |
24,995
+10,224
| +69% | +$1.42M |
|
1361
Popular Inc
BPOP
$11.3B
| $3.44M | ﹤0.01% |
42,042
-1,984
| -5% | -$175K |
|
1362
AstraZeneca
AZN
$243B
| $3.44M | ﹤0.01% |
25,899
+17,780
| +219% | +$2.13M |
|
1363
Vanguard Total International Stock ETF
VXUS
$164B
| $3.43M | ﹤0.01% |
+57,462
| New | +$3.5M |
|
|
UNIT
1364
Uniti Group
UNIT
$2.43B
| $3.43M | ﹤0.01% |
249,238
-76,680
| -24% | -$971K |
|
1365
Manhattan Associates
MANH
$11.5B
| $3.41M | ﹤0.01% |
24,559
-12,729
| -34% | -$1.7M |
|
1366
CALL
Allstate
ALL
$66.1B
| $3.39M | ﹤0.01% |
245
+71
| +41% | +$8.91K |
|
1367
CALL
DaVita
DVA
$11.5B
| $3.39M | ﹤0.01% |
+300
| New | +$33.7K |
|
1368
BCE
BCE
$21.9B
| $3.39M | ﹤0.01% |
61,165
+56,265
| +1,148% | +$2.98M |
|
1369
iShares MBS ETF
MBB
$39.1B
| $3.38M | ﹤0.01% |
33,166
-151,248
| -82% | -$15.8M |
|
1370
Jones Lang LaSalle
JLL
$17.3B
| $3.38M | ﹤0.01% |
14,095
-20,541
| -59% | -$5.01M |
|
1371
Reinsurance Group of America
RGA
$16.3B
| $3.37M | ﹤0.01% |
30,823
-28,450
| -48% | -$3.15M |
|
1372
RenaissanceRe
RNR
$13.4B
| $3.37M | ﹤0.01% |
21,284
-1,321
| -6% | -$205K |
|
|
EXAS
1373
PUT
DELISTED
Exact Sciences
EXAS
| $3.37M | ﹤0.01% |
+482
| New | +$35.2K |
|
1374
PUT
Sherwin-Williams
SHW
$87.2B
| $3.37M | ﹤0.01% |
135
-3,748
| -97% | -$1.04M |
|
1375
Ionis Pharmaceuticals
IONS
$9.51B
| $3.37M | ﹤0.01% |
90,936
-215,317
| -70% | -$7.05M |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.